Mixed methods evaluation of targeted case finding for cardiovascular disease prevention using a stepped wedged cluster RCT

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Marshall, Tom ^a   Caley, Michael ^b   Hemming, Karla ^a   Gill, Paramjit ^a   Gale, Nicola ^a   Jolly, Kate ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Warwickshire Primary Care Trust   (United Kingdom)

Author keywords

Cardiovascular diseases; Cluster randomised controlled trial; Prevention; Risk factors; Statinsm

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; UNITED KINGDOM;

ADULT; AGED; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; ELECTRONIC HEALTH RECORDS; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MIDDLE AGED; PATIENT SELECTION; PRIMARY HEALTH CARE; PROGRAM EVALUATION; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 84867806304     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-908     Document Type: Article

References (36)

1. National Institute for Clinical Excellence, Hypertension Management of hypertension in adults in primary care National Institute for Clinical Excellence 2004 Clinical Guideline 18 www.nice.org.uk/CG018NICEguideline Last accessed 26th July 2009
2. National Institute for Health and Clinical Excellence, Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease 2008 http://guidance.nice.org.uk/ CG67 ] (Last accessed 26th July 2009)
3. Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart UK, Primary Care Cardiovascular Society, The Stroke Association Prepared by: British Cardiac Society, British Hypertension Society, Diabetes UK, JBS 2, Heart 2005 91 1 52 10.1136/hrt.2004.042515 15604317 (Pubitemid 39664976)
4. Scottish Intercollegiate, Guidelines Network SIGN 97 Risk estimation and the prevention of cardiovascular disease a national clinical guideline Scottish Intercollegiate Guidelines Network 2007 http://www.sign.ac.uk/guidelines/ fulltext/93-97/index.html Last accessed 9th May 2012
5. National Institute for Clinical Excellence, CG71 Familial hypercholesterolaemia: NICE guideline 2008 http://publications.nice.org.uk/ lipid-modification-cg71 Last accessed 24th April 2012
6. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A, Antithrombotic Trialists' (ATT) Collaboration, Lancet 2009 373 9678 1849 1860 10.1016/S0140-6736(09)60503-1 19482214
7. Quality of Cardiovascular disease preventive care and physician/practice characteristics. Christian A, Millls T, Simpson S, Mosca L, J Gen Intern Med 2006 21 3 231 237 10.1111/j.1525-1497.2006.00331.x 16637822
8. A global survey of physicians' perceptions on cholesterol management: the From The Heart study. Erhardt LR, Hobbs FD, Int J Clin Pract 2007 61 7 1078 1085 10.1111/j.1742-1241.2007.01420.x 17577295 (Pubitemid 46934631)
9. Clinical inertia: a common barrier to changing provider prescribing behavior. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, Liu X, Alvarez V, Dittus RS, Speroff T, Joint Comm J Qual Patient Saf 2007 33 5 277 285
10. Management of hypertension and the core services guidelines: results from interviews with 100 Auckland general practitioners. Arroll B, Jenkins S, North D, Kearns R, New Zeal Med J 1995 108 55 57 7885648
11. GPs decisions on drug treatment for patients with high cholesterol values: a think-aloud study. Backlund L, Skaner Y, Montgomery H, Bring J, Strender L, BMC Med Informat Decis Making 2004 4 23 10.1186/1472-6947-4-23 (Pubitemid 40132262)
12. Barriers to adherence to hypertension guidelines among GPs in south Sweden: A survey. Midlöv P, Ekenbo R, Johansson L, Gerward S, Persson K, Nerbrand C, Hedblad B, Scand J of Prim Health Care 2008 26 3 154 159 10.1080/02813430802202111
13. How general practitioners perceive and grade the cardiovascular risk of their patients. Roncaglioni MC, Avanzini F, Roccatagliata D, Monesi L, Tamayo-Benitez D, Tombesi M, Caimi V, Longoni P, Lauri D, Barlera S, Tognoni G, Collaborative Group Risk and Prevention Study, Eur J Cardiovasc Prev Rehabil 2004 11 3 233 238 10.1097/01.hjr.0000129737.84851.99 15179106 (Pubitemid 38870072)
14. Coronary risk estimates and decisions on lipid-lowering treatment in primary prevention: Comparison between general practitioners, internists, and cardiologists. Vancheria F, Strender LE, Montgomery H, Skånér Y, Backlund LG, Eur J Intern Med 2009 20 6 601 606 10.1016/j.ejim.2009.04.002 19782921
15. Estimation of cardiovascular risk in hypertensive patients in primary care. Montgomery AA, Fahey T, MacKintosh C, Sharp DJ, Peters TJ, Br J Gen Pract 2000 451 2 127 128 (Pubitemid 30076681)
16. The NHS Information Centre Health Survey for England, Trend tables Publication date: December 16, 2010 2009 http://www.ic.nhs.uk/pubs/hse09trends Last accessed 4th January 2012
17. Department of Health, Putting prevention first: Vascular checks risk assessment and management-impact assessment London: Department of Health 2008
18. Department of Health, Economic Modelling for Vascular Checks 2008 cited 3rd December 2009) Available from URL: http://www.dh.gov.uk/prod-consum-dh/ groups/dh-digitalassets/@dh/@en/documents/digitalasset/dh-085917.pdf
19. Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study. Marshall T, Rouse A, Br Med J 2002 325 197 199 10.1136/bmj.325.7357.197 (Pubitemid 34827893)
20. The value of information: modelling the efficiency of strategies for identifying high-risk patients for primary prevention of cardiovascular disease. Marshall T, Informat Prim Care 2006 14 85 92 (Pubitemid 44687599)
21. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. Chamnan P, Simmons RK, Khaw KT, Wareham NJ, Griffin SJ, BMJ 2010 340 1693 10.1136/bmj.c1693 20418545
22. The Sandwell Project: a controlled evaluation of a programme of targeted screening for prevention of cardiovascular disease in primary care. Marshall T, Westerby P, Chen J, Fairfield M, Harding J, Westerby R, Ahmad R, Middleton J, BMC Publ Health 2008 8 73 10.1186/1471-2458-8-73 (Pubitemid 351473764)
23. The stepped wedge trial design a systematic review. Brown CA, Lilford RJ, BMC Med Res Meth 2006 6 54 10.1186/1471-2288-6-54
24. Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation. Mdegea ND, Mana MS, Celia A, Taylor CA, Torgerson DJ, J Clin Epidemiol 2011 64 936 948 10.1016/j.jclinepi.2010.12.003 21411284
25. The Gambia Hepatitis Intervention Study. Gambia Hepatitis Study Group, Canc Res 1987 47 5782 7
26. MSD Informatics Clinical Manager, http://www.msdinformatics.com/ClinMan. htm Last accessed 4th January 2012
27. Cardiovascular disease risk profiles. Anderson KM, Odell PM, Wilson PW, Kannel WB, Am Hear J 1991 121 1 Pt 2 293 298
28. Identification of patients for clinical risk assessment by prediction of cardiovascular risk using default risk factor values. Marshall T, BMC Publ Health 2008 8 25 10.1186/1471-2458-8-25. PMCID: PMC2244603
29. British National Formulary BMJ Group and the Royal Pharmaceutical Society of Great Britain, 2011 http://bnf.org/bnf/index.htm Last accessed 5th January 2012
30. Office of National Statistics, UK indices of multiple deprivation-a way to make comparisons across constituent countries easier http://www.ons.gov.uk/ ons/rel/hsq/health-statistics-quarterly/no - 53 - spring-2012/uk-indices-of- multiple-deprivation.html Last accessed 2nd Sept 2012
31. Developments in cluster randomised trial and Statistics in Medicine. Campbell MJ, Donner A, Klar N, Statistics in Medicine 2007 26 2 19 10.1002/sim.2731 17136746 (Pubitemid 46099414)
32. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ, J Clin Epidemiol 2004 57 8 785 794 10.1016/j.jclinepi. 2003.12.013 15485730 (Pubitemid 39370161)
33. Sample size calculations for cluster randomised controlled trials with a fixed number of clusters. Hemming K, Girling AJ, Sitch AJ, Marsh J, Lilford RJ, BMC Med Res Methodol 2011 11 102 10.1186/1471-2288-11-102 21718530
34. Talking about pictures: a case for photo elicitation. Harper D, Vis Stud 2002 17 1 13 26 10.1080/14725860220137345
35. Medical Research Council clinical trials series, Cluster randomised trials-Methodological and ethical considerations 2002 http://www.mrc.ac.uk/ Utilities/Documentrecord/index.htm?d=MRC002406 Last accessed 1st February 2012
36. Design and analysis of stepped wedge cluster randomized trials. Hussey MA, Hughes JP, Contemp Clin Trials 2007 28 2 182 191 Epub 2006 Jul 7 10.1016/j.cct.2006.05.007 16829207 (Pubitemid 44937879)